EPILEPSY: TWO DRUGS ARE NOT NECESSARILY BETTER THAN ONE! Newsletter Article 13 February 2013 Pages: 2 - 2
BROMOCRIPTINE: POPULAR CHOICE IN THE EDITORIALS THIS WEEK Newsletter Article 13 February 2013 Pages: 3 - 4
REVERSIBLE HAEMOLYSIS NOW ASSOCIATED WITH HYDRALLAZINE Newsletter Article 13 February 2013 Pages: 5 - 5
MEGALOBLASTIC ANAEMIA ASSOCIATED WITH SULPHASALAZINE Newsletter Article 13 February 2013 Pages: 5 - 5
MINOXIDIL LOWERS BLOOD PRESSURE — BUT SIDE-EFFECTS RESTRICT ITS USE Newsletter Article 13 February 2013 Pages: 8 - 8
DISULFIRAM IMPLANTS SEEM TO BE EFFECTIVE IN CHRONIC ALCOHOLICS Newsletter Article 13 February 2013 Pages: 8 - 9
PATIENTS PREFER ‘PARAFON FORTE’ OVER ‘NORGESIC FORTE’ Newsletter Article 13 February 2013 Pages: 9 - 9
IMPORTANT FIVE-YEAR SWEDISH STUDY OF DRUG PRESCRIBING Newsletter Article 13 February 2013 Pages: 10 - 11
OUTPATIENT TREATMENT OF ACUTE PELVIC INFLAMMATORY DISEASE Newsletter Article 13 February 2013 Pages: 12 - 12
MEFLOQUINE: IMPRESSIVE RESULTS IN FALCIPARUM MALARIA Newsletter Article 13 February 2013 Pages: 13 - 13
NEW IV RIFAMPICIN IS COMPARABLE TO THE ORAL FORMULATION Newsletter Article 13 February 2013 Pages: 15 - 15
‘DEPO-PROVERA’ — A CONTRACEPTIVE WHICH PROMOTES LACTATION? Newsletter Article 13 February 2013 Pages: 15 - 15
PIVMECILLINAM PHARMACOKINETICS IN COELIAC DISEASE ARE UNCHANGED Newsletter Article 13 February 2013 Pages: 15 - 15
NEW FORMULATION PROLONGS ACTIVE BLOOD LEVELS OF PAPAVERINE Newsletter Article 13 February 2013 Pages: 16 - 16
THEOPHYLLINE DISPOSITION VARIES IN PATIENTS WITH CIRRHOSIS Newsletter Article 13 February 2013 Pages: 16 - 16
ELIMINATION OF DIGOXIN IS DECREASED IN PREMATURE BABIES Newsletter Article 13 February 2013 Pages: 16 - 16
IS AN ANSWER TO THE BREAST CANCER QUANDARY ANY NEARER? Newsletter Article 13 February 2013 Pages: 17 - 18